Subtle Medical, an Artificial Intelligence (AI)-empowered medical imaging company based in Guangdong, has reportedly raised “tens of millions” of US dollars in a Series B financing round. The round was led by Eastern Bell Capital and Primavera Venture Partners, with contributions from Fusion Fund, 3E Bioventures, Banyan Pacific Capital, Delta Capital, and European funds Crista Galli Ventures and Catchlight Capital. The proceeds will be used to further develop and commercialize Subtle Medical’s innovative AI imaging solutions.
Company Profile
Subtle Medical boasts a suite of advanced imaging products, including SubtlePET and SubtleMR, which have obtained four market approvals in the US and four CE certificates in Europe. The company has also secured market approvals in China, South America, Canada, Singapore, Australia, and other regions. Its image generation acceleration product, SubtleSynth, is awaiting regulatory decisions in the US. Subtle Medical has also partnered with German giant Bayer in relation to its SubtleGAD.
Partnerships and Future Plans
Subtle Medical has established a series of high-profile partnerships with leading medical institutions globally. These include Stanford University School of Medicine, UCSF School of Medicine, MD Anderson Cancer Center, Mount Sinai Medical Center, University of Pittsburgh Medical Center, and others. In China, the company has partnered with Ruijin Hospital, Beijing Tiantan Hospital, and Health 100, among others. These collaborations underscore Subtle Medical’s commitment to advancing AI-powered medical imaging solutions and enhancing clinical outcomes.
Future Implications
The Series B funding marks a significant step for Subtle Medical in its mission to transform medical imaging through AI. This investment will support the company’s ongoing R&D efforts and accelerate the global adoption of its innovative imaging technologies. By leveraging AI, Subtle Medical aims to improve diagnostic accuracy and efficiency, ultimately benefiting patients and healthcare providers worldwide.-Fineline Info & Tech
